Highlights Maravai LifeSciences Holdings, Inc.

Equities

MRVI

US56600D1072

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
8.61 ^USD	+1.77%		-0.69%	+31.45%

May. 15	Transcript : Maravai LifeSciences Holdings, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-15-2024 03:35 PM
May. 09	UBS Raises Price Target on Maravai LifeSciences to $8.50 From $6.50, Maintains Neutral Rating	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Reports Q1 Revenue $64.2M, vs. Street Est of $60.5M	May. 08	MT
Maravai LifeSciences Holdings, Inc. Reaffirms Financial Guidance for the Full Year 2024	May. 08	CI
Maravai LifeSciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Maravai LifeSciences Unit Opens New Manufacturing Facility in San Diego	Apr. 18	MT
Maravai LifeSciences Shares Surge After Price Target Raises, Q4 Beat	Feb. 23	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday	Feb. 23	MT
Maravai LifeSciences' Q4 Adjusted Earnings, Revenue Decline	Feb. 23	MT
Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Reports Q4 Revenue $74.1M, vs. Street Est of $64.3M	Feb. 22	MT
Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Posts Q4 EPS $0.01, vs. Street Est of $-0.01	Feb. 22	MT
Maravai LifeSciences Holdings, Inc. Provides Earnings Guidance for the Fiscal Year 2024	Feb. 22	CI
Maravai LifeSciences Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22	CI
Dyadic International Partners With Maravai LifeSciences' Cygnus Technologies Unit on HCP Assay	Feb. 13	MT
Maravai LifeSciences Holdings Seeks Acquisitions	Nov. 07	CI
Maravai LifeSciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Maravai LifeSciences Holdings, Inc. Provides Updated Earnings Guidance for the Full Year 2023	Nov. 07	CI
TriLink BioTechnologies Expands Capabilities with Launch of 'Analytical Sciences Center of Excellence'	Nov. 02	CI
Maravai LifeSciences Says Targeting $700 Million in Revenue in 2028	23-09-29	MT
Maravai LifeSciences Holdings Reports Q2 Breakeven Adjusted Earnings, Lower Revenue; Cuts Full Year Guidance	23-08-07	MT
Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Posts Q2 Revenue $68.9M, vs. Street Est of $71.1M	23-08-07	MT
Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Reports Q2 EPS $0.00, vs. Street Est of $0.01	23-08-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Maravai LifeSciences Holdings, Inc.

Equities

MRVI

US56600D1072

Highlights

Filters